Patrick J Lao1,2, Tobey J Betthauser1,2, Dana L Tudorascu3, Todd E Barnhart1, Ansel T Hillmer4, Charles K Stone5, Jogeshwar Mukherjee6, Bradley T Christian1,2,7. 1. Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, 53705. 2. Waisman Laboratory for Brain Imaging and Behavior, Madison, Wisconsin, 53705. 3. Department of Medicine, Biostatistics, Psychiatry, and Clinical and Translational Science, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213. 4. Department of Radiology and Biomedical Imaging, and Psychiatry, Yale University, New Haven, Connecticut, 06520. 5. Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, 53705. 6. Department of Radiological Sciences, University of California-Irvine, Irvine, California, 92697. 7. Department of Psychiatry, University of Wisconsin-Madison, Madison, Wisconsin, 53705.
Abstract
The aim of this study was to examine the suitability of [18 F]nifene, a novel α4β2* nicotinic acetylcholine receptor (nAChR) radiotracer, for in vivo brain imaging in a first-in-human study. METHODS: Eight healthy subjects (4 M,4 F;21-69,44 ± 21 yrs) underwent a [18 F]nifene positron emission tomography scan (200 ± 3.7 MBq), and seven underwent a second scan within 58 ± 31 days. Regional estimates of DVR were measured using the multilinear reference tissue model (MRTM2) with the corpus callosum as reference region. DVR reproducibility was evaluated with test-retest variability (TRV) and intraclass correlation coefficient (ICC). RESULTS: The DVR ranged from 1.3 to 2.5 across brain regions with a TRV of 0-7%, and did not demonstrate a systematic difference between test and retest. The ICCs ranged from 0.2 to 0.9. DVR estimates were stable after 40 min. CONCLUSION: The binding profile and tracer kinetics of [18 F]nifene make it a promising α4β2* nAChR radiotracer for scientific research in humans, with reliable DVR test-retest reproducibility.
The aim of this study was to examine the suitability of [18 F]nifene, a novel α4β2* nicotinic acetylcholine receptor (nAChR) radiotracer, for in vivo brain imaging in a first-in-human study. METHODS: Eight healthy subjects (4 M,4 F;21-69,44 ± 21 yrs) underwent a [18 F]nifene positron emission tomography scan (200 ± 3.7 MBq), and seven underwent a second scan within 58 ± 31 days. Regional estimates of DVR were measured using the multilinear reference tissue model (MRTM2) with the corpus callosum as reference region. DVR reproducibility was evaluated with test-retest variability (TRV) and intraclass correlation coefficient (ICC). RESULTS: The DVR ranged from 1.3 to 2.5 across brain regions with a TRV of 0-7%, and did not demonstrate a systematic difference between test and retest. The ICCs ranged from 0.2 to 0.9. DVR estimates were stable after 40 min. CONCLUSION: The binding profile and tracer kinetics of [18 F]nifene make it a promising α4β2* nAChR radiotracer for scientific research in humans, with reliable DVR test-retest reproducibility.
Authors: John M Floberg; Charles A Mistretta; Jamey P Weichert; Lance T Hall; James E Holden; Bradley T Christian Journal: Med Phys Date: 2012-06 Impact factor: 4.071
Authors: Alane S Kimes; Svetlana I Chefer; John A Matochik; Carlo S Contoreggi; D Bruce Vaupel; Elliot A Stein; Alexey G Mukhin Journal: Neuroimage Date: 2007-09-19 Impact factor: 6.556
Authors: A T Hillmer; D W Wooten; J M Moirano; M Slesarev; T E Barnhart; J W Engle; R J Nickles; D Murali; M L Schneider; J Mukherjee; B T Christian Journal: Synapse Date: 2011-08-31 Impact factor: 2.562
Authors: Ansel T Hillmer; Dana L Tudorascu; Dustin W Wooten; Patrick J Lao; Todd E Barnhart; Elizabeth O Ahlers; Leslie M Resch; Julie A Larson; Alexander K Converse; Colleen F Moore; Mary L Schneider; Bradley T Christian Journal: Drug Alcohol Depend Date: 2014-02-15 Impact factor: 4.492
Authors: Hiroto Kuwabara; Yongjun Gao; Michael Stabin; Jennifer Coughlin; Sridhar Nimmagadda; Robert F Dannals; Martin G Pomper; Andrew G Horti Journal: Mol Imaging Biol Date: 2017-04 Impact factor: 3.488
Authors: Ansel T Hillmer; Dustin W Wooten; Maxim S Slesarev; Elizabeth O Ahlers; Todd E Barnhart; Dhanabalan Murali; Mary L Schneider; Jogeshwar Mukherjee; Bradley T Christian Journal: J Nucl Med Date: 2012-07-31 Impact factor: 10.057
Authors: Alexander Hammers; Marie-Claude Asselin; Federico E Turkheimer; Rainer Hinz; Safiye Osman; Gary Hotton; David J Brooks; John S Duncan; Matthias J Koepp Journal: Neuroimage Date: 2007-07-24 Impact factor: 6.556
Authors: Anthony-David T Campoy; Christopher Liang; Reisha M Ladwa; Krystal K Patel; Ishani H Patel; Jogeshwar Mukherjee Journal: Molecules Date: 2021-12-04 Impact factor: 4.411
Authors: Tobey J Betthauser; Ansel T Hillmer; Patrick J Lao; Emily Ehlerding; Jogeshwar Mukherjee; Charles K Stone; Bradley T Christian Journal: Nucl Med Biol Date: 2017-08-17 Impact factor: 2.408